Form 4: KORU Medical Director Acquires Shares

KORU Medical Systems Director Matin Shahriar acquired 2,581 shares of common stock at $5.81 per share, increasing direct beneficial ownership to 94,101 shares.

Summary

• Matin Shahriar, a Director of KORU Medical Systems, Inc. (KRMD), acquired 2,581 shares of common stock.
• The transaction occurred on January 2, 2026, at a price of $5.81 per share.
• Following this acquisition, Matin Shahriar directly beneficially owns 94,101 shares of KORU Medical Systems common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially under a 10b5-1 plan, generally indicates insider confidence in the company's future, which is a positive signal for investors.

Positives

• A Director, Matin Shahriar, increased their direct beneficial ownership in KORU Medical Systems, Inc. by acquiring 2,581 shares.
• The acquisition was made at a price of $5.81 per share, indicating a specific valuation point for the insider.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned investment strategy and reducing the perception of opportunistic trading.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports an insider transaction.

Industry Context

Insider buying, particularly by a director, can signal confidence in the company's future prospects within the medical systems industry. This is a routine disclosure for insider transactions, providing transparency into management's holdings.

Comparison to Industry Standards

• Insider buying activity is a common occurrence across all industries, including medical systems. The acquisition of shares by a director is generally viewed as a positive signal, aligning management's interests with shareholders.
• While specific industry benchmarks for insider buying volume or frequency are not provided, this transaction is consistent with typical insider reporting practices.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the director's purchase as a positive signal of confidence in the company's future performance and valuation, potentially influencing investor sentiment.
• Management/Employees: Reinforces alignment of interests between leadership and the company's success, potentially boosting morale and commitment.

Key Dates

Recommendation

A director's acquisition of shares signals confidence in the company's prospects and aligns their interests with shareholders. However, this single transaction, while positive, does not provide sufficient comprehensive financial or strategic information to warrant a strong buy or sell recommendation. It serves as a positive data point for investors to consider within their broader analysis of KORU Medical Systems.

Keywords

KORU Medical Systems, KRMD, Insider Trading, Form 4, Stock Acquisition, Director, Matin Shahriar, Rule 10b5-1